论文信息 - Donanemab (LY3002813) Phase 1b Study in Alzheimer’s Disease: Rapid and Sustained Reduction of Brain Amyloid Measured by Florbetapir F18 Imaging - 字舞流文

Donanemab (LY3002813) Phase 1b Study in Alzheimer’s Disease: Rapid and Sustained Reduction of Brain Amyloid Measured by Florbetapir F18 Imaging

A. Fleisher | J. Dage | S. Shcherbinin | B. Willis | I. Gueorguieva | S. Lowe | P. Ardayfio | M. Ishibai | L. Chua | J. Sims | Y-j Cheng | G. Takaichi | A. Lo | C. Duggan Evans | G. Mullins | G. Aguiar | G. Takaichi